|
FBIO | Fortress Biotech, Inc. |
|
|
FBIO | Fortress Biotech, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.55 |
| Leverage | 64.07% |
| Market Cap | $ 42.1m |
| PE | 10.90 |
| Dividend Yield | 0.00% |
| Profit | $ 3.9m |
| Margin | 6.05% |
Fortress Biotech, Inc., a biopharmaceutical company, develops and markets pharmaceutical and biotech products. The company is headquartered in New York, New York.